Radius Health, Inc. logo

Radius Health, Inc.

NASDAQ:RDUS

Overview | Financials
Company Name Radius Health, Inc.
Symbol RDUS
Currency USD
Price 14.68
Market Cap 408,683,860
Dividend Yield 3.85%
52-week-range 12.69 - 31.7
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Jesper Hoiland
Website https://radiuspharm.com

An error occurred while fetching data.

About Radius Health, Inc.

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical

Related Stocks

Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc.

EWTX

17.52 USD

Eiger BioPharmaceuticals, Inc. logo

Eiger BioPharmaceuticals, Inc.

EIGR

1.725 USD

LianBio logo

LianBio

LIAN

0.319 USD

Zynex, Inc. logo

Zynex, Inc.

ZYXI

7.84 USD

Aadi Bioscience, Inc. logo

Aadi Bioscience, Inc.

AADI

1.83 USD

Talaris Therapeutics, Inc. logo

Talaris Therapeutics, Inc.

TALS

2.72 USD

Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc.

PHAT

17.72 USD

Financials

Numbers are in millions USD

Numbers are in millions USD